Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

1.

Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries.

Deogaonkar R, Hutubessy R, van der Putten I, Evers S, Jit M.

BMC Public Health. 2012 Oct 16;12:878. doi: 10.1186/1471-2458-12-878. Review.

PMID:
23072714
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review.

Ozawa S, Mirelman A, Stack ML, Walker DG, Levine OS.

Vaccine. 2012 Dec 17;31(1):96-108. doi: 10.1016/j.vaccine.2012.10.103. Epub 2012 Nov 8. Review.

PMID:
23142307
[PubMed - indexed for MEDLINE]
3.

Influenza vaccines in low and middle income countries: a systematic review of economic evaluations.

Ott JJ, Klein Breteler J, Tam JS, Hutubessy RC, Jit M, de Boer MR.

Hum Vaccin Immunother. 2013 Jul;9(7):1500-11. doi: 10.4161/hv.24704. Epub 2013 May 31. Review.

PMID:
23732900
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus.

Bärnighausen T, Bloom DE, Cafiero ET, O'Brien JC.

Clin Microbiol Infect. 2012 Oct;18 Suppl 5:70-6. doi: 10.1111/j.1469-0691.2012.03977.x. Epub 2012 Aug 6. Review.

PMID:
22882176
[PubMed - indexed for MEDLINE]
5.

Using private demand studies to calculate socially optimal vaccine subsidies in developing countries.

Cook J, Jeuland M, Maskery B, Lauria D, Sur D, Clemens J, Whittington D.

J Policy Anal Manage. 2009 Winter;28(1):6-28.

PMID:
19090047
[PubMed - indexed for MEDLINE]
6.

Health economic research on vaccinations and immunisation practices--an introductory primer.

Szucs TD.

Vaccine. 2005 Mar 18;23(17-18):2095-103. Review.

PMID:
15755578
[PubMed - indexed for MEDLINE]
7.

The clinical effectiveness and cost-effectiveness of home-based, nurse-led health promotion for older people: a systematic review.

Tappenden P, Campbell F, Rawdin A, Wong R, Kalita N.

Health Technol Assess. 2012;16(20):1-72. doi: 10.3310/hta16200. Review.

PMID:
22490205
[PubMed - indexed for MEDLINE]
Free Article
8.

The impact of new vaccine introduction on immunization and health systems: a review of the published literature.

Hyde TB, Dentz H, Wang SA, Burchett HE, Mounier-Jack S, Mantel CF; New Vaccine Introduction Impact Published Literature Working Group.

Vaccine. 2012 Oct 5;30(45):6347-58. doi: 10.1016/j.vaccine.2012.08.029. Epub 2012 Aug 29. Review.

PMID:
22940378
[PubMed - indexed for MEDLINE]
9.

The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.

Isaacman DJ, Strutton DR, Kalpas EA, Horowicz-Mehler N, Stern LS, Casciano R, Ciuryla V.

Clin Ther. 2008 Feb;30(2):341-57. doi: 10.1016/j.clinthera.2008.02.003. Review.

PMID:
18343273
[PubMed - indexed for MEDLINE]
10.

Health economics of rubella: a systematic review to assess the value of rubella vaccination.

Babigumira JB, Morgan I, Levin A.

BMC Public Health. 2013 Apr 29;13:406. doi: 10.1186/1471-2458-13-406. Review.

PMID:
23627715
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Paying for performance to improve the delivery of health interventions in low- and middle-income countries .

Witter S, Fretheim A, Kessy FL, Lindahl AK.

Cochrane Database Syst Rev. 2012 Feb 15;2:CD007899. doi: 10.1002/14651858.CD007899.pub2. Review.

PMID:
22336833
[PubMed - indexed for MEDLINE]
12.
13.

Rethinking the benefits and costs of childhood vaccination: the example of the Haemophilus influenzae type b vaccine.

Bärnighausen T, Bloom DE, Canning D, Friedman A, Levine OS, O'Brien J, Privor-Dumm L, Walker D.

Vaccine. 2011 Mar 16;29(13):2371-80. doi: 10.1016/j.vaccine.2010.11.090. Epub 2010 Dec 13.

PMID:
21159324
[PubMed - indexed for MEDLINE]
14.

Cost-benefit comparisons of investments in improved water supply and cholera vaccination programs.

Jeuland M, Whittington D.

Vaccine. 2009 May 18;27(23):3109-20. doi: 10.1016/j.vaccine.2009.02.104. Epub 2009 Mar 10.

PMID:
19428925
[PubMed - indexed for MEDLINE]
15.

Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden.

Kim SY, Sweet S, Chang J, Goldie SJ.

BMC Infect Dis. 2011 Jun 16;11:174. doi: 10.1186/1471-2334-11-174.

PMID:
21679420
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Health and economic impact of rotavirus vaccination in GAVI-eligible countries.

Kim SY, Sweet S, Slichter D, Goldie SJ.

BMC Public Health. 2010 May 14;10:253. doi: 10.1186/1471-2458-10-253.

PMID:
20470426
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness.

Rheingans R, Atherly D, Anderson J.

Vaccine. 2012 Apr 27;30 Suppl 1:A15-23. doi: 10.1016/j.vaccine.2012.01.018.

PMID:
22520124
[PubMed - indexed for MEDLINE]
18.

Economic evaluations of adult weight management interventions: a systematic literature review focusing on methods used for determining health impacts.

Griffiths UK, Anigbogu B, Nanchahal K.

Appl Health Econ Health Policy. 2012 May 1;10(3):145-62. doi: 10.2165/11599250-000000000-00000. Review.

PMID:
22439628
[PubMed - indexed for MEDLINE]
19.

Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches.

Kim SY, Goldie SJ.

Pharmacoeconomics. 2008;26(3):191-215. Review.

PMID:
18282015
[PubMed - indexed for MEDLINE]
20.

Slum upgrading strategies involving physical environment and infrastructure interventions and their effects on health and socio-economic outcomes.

Turley R, Saith R, Bhan N, Rehfuess E, Carter B.

Cochrane Database Syst Rev. 2013 Jan 31;1:CD010067. doi: 10.1002/14651858.CD010067.pub2. Review.

PMID:
23440845
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk